As of 2025-05-23, the Intrinsic Value of Cian Healthcare Ltd (542678.BO) is 0.88 INR. This 542678.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 3.55 INR, the upside of Cian Healthcare Ltd is -75.30%.
The range of the Intrinsic Value is (4.65) - 15.49 INR
Based on its market price of 3.55 INR and our intrinsic valuation, Cian Healthcare Ltd (542678.BO) is overvalued by 75.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (4.65) - 15.49 | 0.88 | -75.3% |
| DCF (Growth 10y) | (2.62) - 18.98 | 3.43 | -3.5% |
| DCF (EBITDA 5y) | 8.01 - 24.06 | 14.20 | 299.9% |
| DCF (EBITDA 10y) | 4.62 - 25.05 | 12.24 | 244.8% |
| Fair Value | -33.04 - -33.04 | -33.04 | -1,030.63% |
| P/E | (103.34) - 6.95 | (49.74) | -1501.1% |
| EV/EBITDA | (0.46) - 10.43 | 5.47 | 54.0% |
| EPV | 3.99 - 21.48 | 12.73 | 258.7% |
| DDM - Stable | (15.68) - (29.66) | (22.67) | -738.6% |
| DDM - Multi | 2.09 - 3.30 | 2.58 | -27.4% |
| Market Cap (mil) | 88.75 |
| Beta | 0.45 |
| Outstanding shares (mil) | 25.00 |
| Enterprise Value (mil) | 616.33 |
| Market risk premium | 8.31% |
| Cost of Equity | 28.78% |
| Cost of Debt | 17.89% |
| WACC | 14.42% |